U.S. Food and Drug Administration
The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the ...
Drugs | FDA - U.S. Food and Drug Administration
Find information about most FDA-approved prescription, generic, and over-the-counter drug products. Drug Shortages Find information about drug shortages caused by manufacturing and quality ...
What We Do | FDA - U.S. Food and Drug Administration
FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate ...
Food | FDA
Commemorating 30-years of the FDA Food Code - a model for best practices to ensure the safe handling of food in a retail setting
Medical Devices | FDA - U.S. Food and Drug Administration
FDA regulates the sale of medical device products in the U.S. and monitors the safety of all regulated medical products.
FDA en español | FDA
La FDA es responsable de proteger la salud pública asegurando la seguridad, eficacia y protección de los medicamentos, los productos biológicos y los dispositivos médicos humanos y ...
FDA Approves Novel Non-Opioid Treatment for Moderate to …
Jan 30, 2025 · The FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
Recalls, Market Withdrawals, & Safety Alerts | FDA
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
Contact FDA | FDA - U.S. Food and Drug Administration
Oct 21, 2024 · View FDA’s proposed regulations and submit comments online (on Regulations.gov). How to comment on proposed regulations or submit petitions. Resolve a dispute. Contact the FDA Ombudsman
Drug Approvals and Databases | FDA
Novel Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products; Drug and Biologic Approval and IND Activity Reports; This Week's Drug Approvals; Drug Trials Snapshots